Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 15, 2007 - Issue 1
Submit an article Journal homepage
87
Views
23
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Photodynamic Therapy for Subfoveal and Juxtafoveal Choroidal Neovascularization Associated with Punctate Inner Choroidopathy

Rosa M. Coco Instituto de Oftalmobiología Aplicada (IOBA), Universidad de Valladolid, Avda. Ramon y Cajal, 7, Valladolid, 47005, Spain
,
Clairton Feitosa de Souza Instituto de Oftalmobiología Aplicada (IOBA), Universidad de Valladolid, Avda. Ramon y Cajal, 7, Valladolid, 47005, Spain
&
M. Rosa Sanabria Instituto de Oftalmobiología Aplicada (IOBA), Universidad de Valladolid, Avda. Ramon y Cajal, 7, Valladolid, 47005, Spain; Hospital Universitario Río Hortega, C/Rondilla de Sta Teresa 9, Valladolid, 47010, Spain
Pages 27-29 | Accepted 11 Dec 2006, Published online: 08 Jul 2009

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Kirill Zaslavsky, Teresa Park, Rachel Lang Mcinnis, Mark Mandell, Jihwan Lee, Christopher Lee, Rose Gilbert & Larissa Derzko-Dzulynsky. (2023) Outcomes in PIC-Related CNV: Pooled Analysis of Individual Participant Data. Ocular Immunology and Inflammation 31:9, pages 1825-1836.
Read now
Dimitrios Brouzas, Antonios Charakidas, Tryfon Rotsos, Marilita M Moschos, Helen Loukianou, Chryssanthy Koutsandrea, Ioannis Ladas & Stefanos Baltatzis. (2010) Choroidal neovascularization due to punctate inner choroidopathy: long-term follow-up and review of literature. Clinical Ophthalmology 4, pages 871-876.
Read now
Priyanka P. Doctor, Pooja Bhat, Reema Sayed & C. Stephen Foster. (2009) Intravitreal Bevacizumab for Uveitic Choroidal Neovascularization. Ocular Immunology and Inflammation 17:2, pages 118-126.
Read now

Articles from other publishers (20)

Wei Wu, Shiying Li, Haiwei Xu, Yong Liu, Yi Wang, Timothy Y. Y. Lai & Zheng Qin Yin. (2018) Treatment of Punctate Inner Choroidopathy with Choroidal Neovascularization Using Corticosteroid and Intravitreal Ranibizumab. BioMed Research International 2018, pages 1-7.
Crossref
Dana Ahnood, Savitha Madhusudhan, Marie D. Tsaloumas, Nadia K. Waheed, Pearse A. Keane & Alastair K. Denniston. (2017) Punctate inner choroidopathy: A review. Survey of Ophthalmology 62:2, pages 113-126.
Crossref
Akio Oishi. 2017. Choroidal Disorders. Choroidal Disorders 117 138 .
Muna Bhende & Arshee S. Ahmed. 2016. Uveitis: An Update. Uveitis: An Update 109 117 .
Adam T. Gerstenblith, Yasir J. Sepah, Jose Ramon Maya, Diana V. Do & Quan Dong Nguyen. 2016. Intraocular Inflammation. Intraocular Inflammation 1013 1019 .
R. C. Andrew Symons, Syed Mahmood Shah, Diana V. Do, Mostafa Hanout, Yasir J. Sepah & Quan Dong Nguyen. 2016. Intraocular Inflammation. Intraocular Inflammation 471 483 .
Yi-Hsuan Li, Cheng-Kuo Cheng & Yu-Tang Tseng. (2015) Clinical characteristics and antivascular endothelial growth factor effect of choroidal neovascularization in younger patients in Taiwan. Taiwan Journal of Ophthalmology 5:2, pages 76-84.
Crossref
Theresa G. Leung, Ahmadreza Moradi, Dianna Liu, Quan D. Nguyen, James P. Dunn, Bryn Burkholder, Nicholas J. Butler, Trucian Ostheimer & Jennifer E. Thorne. (2014) CLINICAL FEATURES AND INCIDENCE RATE OF OCULAR COMPLICATIONS IN PUNCTATE INNER CHOROIDOPATHY. Retina 34:8, pages 1666-1674.
Crossref
Enzo D?Ambrosio, Paolo Tortorella & Ludovico Iannetti. (2014) Management of Uveitis-Related Choroidal Neovascularization: From the Pathogenesis to the Therapy. Journal of Ophthalmology 2014, pages 1-6.
Crossref
Han Zhang, Zhe-Li Liu, Peng Sun & Feng Gu. (2012) INTRAVITREAL BEVACIZUMAB AS PRIMARY TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO PUNCTATE INNER CHOROIDOPATHY. Retina 32:6, pages 1106-1113.
Crossref
Sophia I. Pachydaki, Frederick A. Jakobiec, Pooja Bhat, Lucia Sobrin, Norman A. Michaud, Surya V. Seshan & Donald J. D’Amico. (2011) Surgical management and ultrastructural study of choroidal neovascularization in punctate inner choroidopathy after bevacizumab. Journal of Ophthalmic Inflammation and Infection 2:1, pages 29-37.
Crossref
Xiongze Zhang, Feng Wen, Chengguo Zuo, Meng Li, Hui Chen, Shizhou Huang & Guangwei Luo. (2011) CLINICAL FEATURES OF PUNCTATE INNER CHOROIDOPATHY IN CHINESE PATIENTS. Retina 31:8, pages 1680-1691.
Crossref
Kevin H Patel, Andrea D Birnbaum, Howard H Tessler & Debra A Goldstein. (2011) PRESENTATION AND OUTCOME OF PATIENTS WITH PUNCTATE INNER CHOROIDOPATHY AT A TERTIARY REFERRAL CENTER. Retina 31:7, pages 1387-1391.
Crossref
Alexander Rouvas, Petros Petrou, Maria Douvali, Amalia Ntouraki, Ioannis Vergados, Ilias Georgalas & Nikolaos Markomichelakis. (2011) INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF INFLAMMATORY CHOROIDAL NEOVASCULARIZATION. Retina 31:5, pages 871-879.
Crossref
Radgonde Amer & Noemi Lois. (2011) Punctate Inner Choroidopathy. Survey of Ophthalmology 56:1, pages 36-53.
Crossref
Victor Menezo, Fiona Cuthbertson & Susan M Downes. (2010) POSITIVE RESPONSE TO INTRAVITREAL RANIBIZUMAB IN THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO PUNCTATE INNER CHOROIDOPATHY. Retina 30:9, pages 1400-1404.
Crossref
Wai Man Chan, Tock-Han Lim, Alfredo Pece, Rufino Silva & Nagahisa Yoshimura. (2010) Verteporfin PDT for non-standard indications—a review of current literature. Graefe's Archive for Clinical and Experimental Ophthalmology 248:5, pages 613-626.
Crossref
M. Stur. (2008) Indikationen für photodynamische Therapie mit Verteporfin im Zeitalter der intravitrealen Therapie – eine ÜbersichtIndications for photodynamic therapy with verteporfin in the age of intravitreal therapy – a review. Spektrum der Augenheilkunde 22:6, pages 340-347.
Crossref
WAI-MAN CHAN, TIMOTHY Y. Y. LAI, TERESA T. Y. LAU, VINCENT Y. W. LEE, DAVID T. L. LIU & DENNIS S. C. LAM. (2008) COMBINED PHOTODYNAMIC THERAPY AND INTRAVITREAL TRIAMCINOLONE FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO PUNCTATE INNER CHOROIDOPATHY OR OF IDIOPATHIC ORIGIN. Retina 28:1, pages 71-80.
Crossref
W. Göbel. (2008) White-Dot-SyndromWhite dot syndrome. Der Ophthalmologe 105:1, pages 91-109.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.